US appeals court rules in favour of further abortion pill restrictions
The US Circuit Court of Appeals restricted the prescription of abortion pills, following action from several anti-abortion groups.
18 August 2023
18 August 2023
The US Circuit Court of Appeals restricted the prescription of abortion pills, following action from several anti-abortion groups.
Priority counties in Africa and Asia will soon receive state-of-the-art laboratories, new genome-sequencing technology, and a strengthened workforce.
The deal allows Coeptis to strengthen its existing SNAP-CAR and GEAR technologies.
The transaction is anticipated to be completed in the fourth quarter of 2023.
The approval is based on results from three Phase III registrational clinical studies, CREDIT-1, CREDIT-2 and CREDIT-4.
As restrictions on abortion drug mifepristone loom, doctors and patients are looking to off-label misoprostol.
The MAA has been submitted based on data from the GATHER1 and GATHER2 Phase III clinical studies.
The company is integrating 15 different HLA types (molecules) into Bria-IMT, collectively referred to as Bria-OTS.
Outsourcing in Clinical Trials Southern California Conference 2023 will be returning to Hyatt Regency La Jolla at Aventine, USA on the 26th-27th September 2023! Focusing on interactive discussions to provide insight into the current major operational issues with running clinical trials in the coming years.
Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.
Give your business an edge with our leading industry insights.